This week’s additions and highlights
1. SPIN-OFFS
- CVS Health (CVS US). CVS Health announced plans to split itself into two companies by spinning off its retail pharmacy business in 2028. The separation will leave the insurance (Aetna) and pharmacy benefits (Caremark) businesses within CVS Health. The market was clearly not happy, probably given the crappy prospects of a standalone retail pharmacy business in a rather bad market.
- Siemens Healthineers (SHL GR). A separation inside a separation. Siemens Healthineers said that it has begun separating its diagnostics (IVD) arm, which will become a standalone company called Olyrian Diagnostics by mid-2028. This comes on top of Siemens’ plan to spin off Healthineers itself with shareholder votes in February 2027. Diagnostics has been the weak spot for years, so getting it out could help the rest re-rate. No structure or value disclosed yet.
- Liberty Global (LBTYA US). Liberty Global completed the buyout of Vodafone’s 50% stake in VodafoneZiggo, so creating Ziggo Group, a Benelux telco with 13m customers and ~€6.6bn revenue. Vodafone receives €1bn cash plus 10% equity, with Liberty owning the remaining 90% and planning an Amsterdam spin‑off in 2027. Management teams are already in place, financial separation across Telenet/Wyre is complete, and €1.2–1.4bn of asset disposals are underway to reduce debt. Liberty frames Ziggo as a regional FCF and dividend compounder. Not a growing asset, but nonetheless one to watch.UPDATE (November 10, 2026) Liberty Global said the Ziggo Group spin is still set for Q2 2027, and put a number on it: ~$13 p/s of tax-free value under its main scenario, or $5-8 p/s if things go less well. Compare that with a share price of ~$11. A reminder of the plan: buy out Vodafone’s half of VodafoneZiggo, merge with Telenet, list Ziggo Group in Amsterdam. Confidential filings with US and Dutch regulators follow in December. It also plans a $100m buyback in Q4, after buying back 2.9% of shares in Q3. Plenty of leverage (EV ~$24bn vs. ~$3bn market cap), but quite the gap.
2. STRATEGIC ALTERNATIVES & REVIEWS
(Potential take-outs, asset sales, M&A, etc.)
- Extreme Networks (EXTR US). Extreme Networks is weighing a sale after getting interest from names like Cisco, Fortinet and NetApp, per reports. It has hired a bank to look at its options. When we flagged its buyback in early 2025, we noted how much the valuation swings around. And it seems the company had good timing buying back shares. Anyways, Extreme is seeing strong growth ahead, which is compressing its forward multiple into the low-teens EV/EBITDA. Snatching it away before it can move much more?…
